Hbcila 1gm Injection
Marketer
Human Bio Organics Pvt Ltd
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Hbcila 1gm Injection
Inj. Hbcila 1g combines antibiotics to combat severe bacterial infections. Its use is restricted to treating serious bacterial illnesses and requires administration by a healthcare provider. Consistent adherence to the prescribed dosage is crucial, completing the entire course regardless of symptom improvement. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation. While these usually resolve, worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) demand prompt emergency care. Prior to initiating treatment, disclose all current medications and pre-existing health conditions to your physician. This is particularly important for pregnant or breastfeeding individuals. Concurrent alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, refrain from operating vehicles if experiencing dizziness or somnolence.
Primary Ingredients of Hbcila 1gm Injection
No information provided. Please provide the text you want me to rewrite.
Uses of Hbcila 1gm Injection
Life-threatening bacterial diseases
Major Benefits of Hbcila 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Hbcila 1gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Hbcila 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Hbcila 1gm Injection works:
Hbcila 1gm Injection merges Imipenem, a bacterium-fighting antibiotic, with Cilastatin, a dehydropeptidase I inhibitor. Imipenem disrupts bacterial cell wall synthesis, hindering their survival. Cilastatin safeguards Imipenem from premature degradation by dehydropeptidase I, thereby extending its therapeutic effectiveness within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Hbcila 1gm Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Hbcila 1gm Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Hbcila 1gm Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingUNSAFE
Administration of Hbcila 1gm Injection may induce adverse reactions that could impair driving capabilities. Certain side effects, including hallucinations (visual, auditory, or tactile), may arise and compromise some individuals' ability to operate a vehicle safely.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Hbcila 1gm Injection. The prescribed dosage of Hbcila 1gm Injection may require modification. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Hbcila 1gm Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Hbcila 1gm Injection :
Omit a scheduled Hbcila 1gm Injection? Seek your physician's advice.
Facts to Know About Hbcila 1gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective medications |
3,018 People bought this recently